Cargando…
Central carbon metabolism in the progression of mammary carcinoma
There is a growing belief that the metabolic program of breast tumor cells could be a therapeutic target. Yet, without detailed information on central carbon metabolism in breast tumors it is impossible to know which metabolic pathways to target, and how their inhibition might influence different st...
Autores principales: | Richardson, Adam D., Yang, Chen, Osterman, Andrei, Smith, Jeffrey W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2440942/ https://www.ncbi.nlm.nih.gov/pubmed/17879159 http://dx.doi.org/10.1007/s10549-007-9732-3 |
Ejemplares similares
-
Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance
por: Abadie, Jérôme, et al.
Publicado: (2017) -
Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors
por: Nguyen, Frédérique, et al.
Publicado: (2017) -
Luminal progenitor and fetal mammary stem cell expression features predict breast tumor response to neoadjuvant chemotherapy
por: Pfefferle, Adam D., et al.
Publicado: (2015) -
The flaxseed lignan secoisolariciresinol diglucoside decreases local inflammation, suppresses NFκB signaling, and inhibits mammary tumor growth
por: Bowers, Laura W., et al.
Publicado: (2018) -
A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancer
por: Hollern, Daniel P., et al.
Publicado: (2018)